Cogent Biosciences
COGT
COGT
186 hedge funds and large institutions have $800M invested in Cogent Biosciences in 2025 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 66 increasing their positions, 52 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 8 → 8 (0)
16% less capital invested
Capital invested by funds: $949M → $800M (-$150M)
75% less call options, than puts
Call options by funds: $355K | Put options by funds: $1.42M
Holders
186
Holding in Top 10
8
Calls
$355K
Puts
$1.42M
Top Buyers
| 1 | +$31.7M | |
| 2 | +$23.5M | |
| 3 | +$22.7M | |
| 4 |
CC
Commodore Capital
New York
|
+$15.8M |
| 5 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$10.7M |
Top Sellers
| 1 | -$33.5M | |
| 2 | -$7.18M | |
| 3 | -$4.07M | |
| 4 |
Walleye Capital
New York
|
-$3.16M |
| 5 |
CM
Crestline Management
Fort Worth,
Texas
|
-$2.88M |